JP Stock MarketDetailed Quotes

4519 Chugai Pharmaceutical

Watchlist
  • 4764.0
  • 0.00.00%
20min DelayTrading May 28 15:00 JST
7.84TMarket Cap24.08P/E (Static)

Chugai Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chugai Pharmaceutical Earnings Date

Currency: JPY

Period

Q1 FY2024 Earnings

Apr 24, 2024

Revenue(YoY)

236.95B

-24.11%
EPS(YoY)

45.21

+1.21%
Analyst Rating

Buy

May 21, 2024

Chugai Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Oct 25, 20242024/Q3-- / 274.605B--
Jul 25, 20242024/Q2-- / 280.246B--
Apr 24, 20242024/Q1236.900B / 242.461B--
Feb 1, 20242023/Q4273.812B / 292.342B--
Oct 24, 20232023/Q3257.898B / 248.026B--
Jul 27, 20232023/Q2267.417B / 236.704B--
Apr 27, 20232023/Q1312.240B / 307.820B--
Feb 2, 20232022/Q4438.446B / 392.775B--
Oct 24, 20222022/Q3225.300B / 272.700B--
Aug 21, 20222022/Q2235.600B / 257.429B--
DatePeriodRevenue/EstimateEarnings Call
Oct 25, 20242024/Q3-- / 274.605B--
Jul 25, 20242024/Q2-- / 280.246B--
Apr 24, 20242024/Q1236.900B / 242.461B--
Feb 1, 20242023/Q4273.812B / 292.342B--
Oct 24, 20232023/Q3257.898B / 248.026B--
Jul 27, 20232023/Q2267.417B / 236.704B--
Apr 27, 20232023/Q1312.240B / 307.820B--
Feb 2, 20232022/Q4438.446B / 392.775B--
Oct 24, 20222022/Q3225.300B / 272.700B--
Aug 21, 20222022/Q2235.600B / 257.429B--

Unlock Free Earnings Estimates

Chugai Pharmaceutical Earnings Reports

  • Chugai Pharmaceutical: Confirmation letter

    Apr 25 01:09

  • Chugai Pharmaceutical: Quarterly Report - 114th Quarter (2024/01/01 to 2024/03/31)

    Apr 25 01:07

  • Chugai Pharmaceutical: Consolidated financial results for the 1st quarter of the fiscal year ending 2024/12 [IFRS] supplementary materials

    Apr 24 03:00

  • Chugai Pharmaceutical: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [IFRS] (consolidated)

    Apr 24 03:00

    • Read more

    Analysis

    Analyst Rating

    Updated: May 21, 2024

    Buy

    • Strong Buy

      42.86%

    • Buy

      14.29%

    • Hold

      42.86%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    %Chg